A Reflection on Blood Cancer Awareness Month: Patient Spotlight

A Giant Step Forward in Developing Clinical Diagnostics and Therapeutics

Adaptive develops new technology to map T cells to the antigens they target, providing the capability to see what diseases the immune system responds to and setting the stage for novel diagnostic tests. New technology to pair the chains of T-cell receptors (TCRs) helps identify which ones have the greatest therapeutic potential.